Seagen, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Seagen, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Seagen, Inc. stocks after a simple registration process. </div>

Q: How to buy Seagen, Inc. shares in India?

<div> To buy Seagen, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Seagen, Inc. and you are done!</div> </div>

Q: What is the share price of Seagen, Inc.?

<div>The share price of Seagen, Inc. is USD 228.74 as on 2 May.</div>

Q: What is the Market Capitalization of Seagen, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Seagen, Inc. is USD 42.93B as on 2 May.</div>

Q: What is the PE ratio of Seagen, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Seagen, Inc. is N/A as on 2 May. </div>

Q: Is Seagen, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Seagen, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Seagen, Inc. operate?

<div> Seagen, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$228.74

(2 May)

Loading Chart

Previous close

$228.74

Open

$228.74

14.37%

27.83%

EPS (TTM)

-4.01

Shares O/S

187.70M

Market cap

42.93B

Insights

SGEN has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

SGEN price is below its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Seagen, Inc.

Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers; TUKYSA, or tucatinib, for the treatment of certain metastatic human epidermal growth factor receptor 2 (HER2) -positive breast and colorectal cancers, and TIVDAK, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers.

It is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients. Its programs including ADCETRIS, PADCEV and TIVDAK, are based on the Company’s antibody-drug conjugate (ADC) technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. .

FAQs

Can I buy Seagen, Inc. shares in India?

How to buy Seagen, Inc. shares in India?

What is the share price of Seagen, Inc.?

What is the Market Capitalization of Seagen, Inc.?

What is the PE ratio of Seagen, Inc.?

Is Seagen, Inc. a good stock to buy?

In which sector / industry does Seagen, Inc. operate?